Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,510,154 papers from all fields of science
Search
Sign In
Create Free Account
C3H/HeJ Mouse
Known as:
C3H/HeJ
Derived from the C3H progenitor strain that was passed to Heston in 1941 and to Jackson Lab in 1947. The C3H/HeJ mouse has an agouti coat color…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Clinical Data Interchange Standards Consortium Terminology
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
1998
1998
Potentiation of cisplatin activity by the bioreductive agent tirapazamine.
D. Siemann
,
C. A. Hinchman
Radiotherapy and Oncology
1998
Corpus ID: 28139753
Highly Cited
1997
Highly Cited
1997
Frequency of micronuclei in the peripheral blood and bone marrow of cancer-prone mice chronically exposed to 2450 MHz radiofrequency radiation.
Vijayalaxmi
,
M. R. Frei
,
S. J. Dusch
,
Veronica Guel
,
M. Meltz
,
J. Jauchem
Radiation Research
1997
Corpus ID: 33071405
C3H/HeJ mice, which are prone to mammary tumors, were exposed for 20 h/day, 7 days/week, over 18 months to continuous-wave 2450…
Expand
1982
1982
Effect of thyroid status on development of spontaneous mammary tumors in primiparous C3H mice.
B. Vonderhaar
,
A. Greco
Cancer Research
1982
Corpus ID: 6703451
Development of mammary tumors in primiparous C3H/HeN mice (mouse mammary tumor virus positive) in various thyroid states was…
Expand
1981
1981
Antiproliferative effects of corticosteroids in C3H/HeJ Mammary tumors and implications for sequential combination chemotherapy.
P. Braunschweiger
,
Lewis M. Schiffer
Cancer Research
1981
Corpus ID: 7203913
Corticosteroid-induced inhibition of cell proliferation and tumor growth was studied in first-generation transplants (FGMT) of…
Expand
1980
1980
Evidence of separate pathways for viral and chemical carcinogenesis in c3h/stwi mouse mammary glands
Gilbert H. Smith
,
Larry A. Arthur
,
D. Medina
International Journal of Cancer
1980
Corpus ID: 44412292
Mammary tumors in mice may arise as the result of exogenous infection with the mouse mammary tumor virus [MMTV(S)], usually via…
Expand
1978
1978
Therapeutic implications of cell kinetic changes after cyclophosphamide treatment in "spontaneous" and "transplantable" mammary tumors.
Branunschweiger Pg
,
Lewis M. Schiffer
Cancer treatment reports
1978
Corpus ID: 5781956
The present studies were initiated to investigate the cell kinetics in spontaneous and transplantable mammary tumors after single…
Expand
1977
1977
Effect of sequence of administration of methotrexate, leucovorin, and 5-fluorouracil on mammary tumor growth and survival in syngeneic C3H mice.
G. Heppner
,
P. Calabresi
Cancer Research
1977
Corpus ID: 22255250
The administration of methotrexate (1mg/kg), leucovorin (1 mg/kg), and (after a 1-hr interval) 5-fluorouracil (50 mg/kg…
Expand
1974
1974
CHANGES IN INSULIN RESPONSIVENESS DURING DEVELOPMENT OF MAMMARY EPITHELIUM
T. Oka
,
J. W. Perry
,
Y. J. Topper
Journal of Cell Biology
1974
Corpus ID: 12488735
Functional differentiation of mammary epithelium normally begins during pregnancy and culminates after parturition . A few weeks…
Expand
Highly Cited
1969
Highly Cited
1969
Spontaneous mammary adenocarcinoma in mice: influence of thymectomy and reconstitution with thymus grafts or spleen cells.
E. Yunis
,
C. Martínez
,
J. Smith
,
O. Stutman
,
R. Good
Cancer Research
1969
Corpus ID: 518776
Neonatally thymectomized C3H MTV+ (mammary tumor virus) female mice which were grafted with syngeneic thymus from either MTV+ or…
Expand
1964
1964
DNA Synthesis in Alveolar Cells of the Mammary Gland: Acceleration by Ovarian Hormones
F. Bresciani
Science
1964
Corpus ID: 13169566
In normal alveolar cells of the mammary gland of C3H/HeJ female mice, DNA synthesis lasts an average of 20.7 hours with a…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE